Changchun, China

Xuesi Chen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Xuesi Chen: Innovator in Biomedical Materials

Introduction

Xuesi Chen is a prominent inventor based in Changchun, China. He has made significant contributions to the field of biomedical materials, particularly through his innovative patents. With a total of 3 patents, Chen's work focuses on developing advanced materials that have practical applications in medicine.

Latest Patents

Chen's latest patents include a polyethylene glycol derivative and a preparation method thereof, as well as a polyethylene glycol hydrogel capable of producing a rapid crosslinking reaction. The polyethylene glycol derivative features a repeat unit with a specific structure and a terminal group that enhances its biocompatibility. This innovation allows for rapid formation of chemically cross-linked hydrogel materials, which are useful as drug carriers and tissue engineering scaffolds. Another notable patent involves a cisplatin complex that demonstrates good biocompatibility and stability, making it advantageous for drug delivery systems.

Career Highlights

Throughout his career, Xuesi Chen has worked with esteemed institutions such as the Chinese Academy of Sciences and the First Hospital of Jilin University. His research has focused on creating materials that improve drug delivery and enhance therapeutic outcomes.

Collaborations

Chen has collaborated with notable colleagues, including Xiabin Jing and Tongjun Liu, contributing to the advancement of biomedical research and innovation.

Conclusion

Xuesi Chen's contributions to the field of biomedical materials through his patents and collaborations highlight his role as a key innovator. His work continues to impact the development of effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…